| Financial Year |
March 31 2023 |
| Monetary Funds |
15,694,344,245.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,058,236.55 |
| Accounts Receivable |
18,859,988,694.29 |
| Advances to Suppliers |
1,072,932,096.69 |
| Other Receivables |
1,431,724,624.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
30,000,000.00 |
| Inventories |
746,556,060.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,580,847,927.39 |
| Total Current Assets |
71,649,659,049.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,668,434,805.07 |
| Long-term Equity Investment |
5,884,359,714.91 |
| Investment Properties |
862,002,051.09 |
| Fixed Assetes |
4,034,631,952.29 |
| Under-construction Projects |
3,767,712,135.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,837,428,944.61 |
| R&D expenses |
-- |
| Goodwill |
60,639,799.48 |
| Long-Term Deferred and Prepaid Expenses |
116,497,799.50 |
| Deferred Income Tax Assets |
420,085,065.43 |
| Other Non-Current Assets |
20,851,132,642.38 |
| Sub-Total of Non-Current Assets |
72,258,413,280.84 |
| Total Assets |
143,908,072,330.21 |
| Short-Term Loans |
8,649,675,884.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
205,409,440.69 |
| Accounts Payable |
57,112,073,461.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
312,988,766.13 |
| Taxes Payable |
797,209,654.02 |
| Interest Payable |
-- |
| Dividend Payable |
14,763,803.99 |
| Other payables |
2,074,826,597.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,639,195,909.55 |
| Other Current Liabilities |
1,372,226,754.98 |
| Sub-Total of Current Liabilities |
80,702,840,042.70 |
| Long-term Loans |
22,893,497,427.25 |
| Bonds Payable |
2,560,672,001.92 |
| Long-Term Accounts Payable |
127,026,762.34 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
630,431,987.47 |
| Other Non-Current Liabilities |
800,437,855.53 |
| Sub-Total of Non-Current Liabilities |
28,918,187,863.41 |
| Total Liabilities |
109,621,027,906.11 |
| Paid-In Capital(Or Share Stock) |
3,144,096,094.00 |
| Capital Surplus |
6,659,699,994.91 |
| Surplus Reserve |
1,428,202,666.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
15,832,629,544.67 |
| Minority Stockholder's Interest |
6,622,741,867.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,664,302,556.44 |
| Owner's Equity（Stockholder's Equity） |
34,287,044,424.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
143,908,072,330.21 |
